Circadian variation of mineral and bone parameters in end-stage renal disease

被引:27
作者
Trivedi, Hariprasad [1 ]
Szabo, Aniko [2 ]
Zhao, Shi [2 ]
Cantor, Tom [3 ]
Raff, Hershel [4 ,5 ]
机构
[1] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA
[3] Scantibodies Lab Inc, Santee, CA USA
[4] Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA
[5] Aurora St Lukes Med Ctr, Aurora Res Inst, Endocrine Res Lab, Milwaukee, WI USA
基金
美国国家卫生研究院;
关键词
Phosphate; Calcium; Parathyroid hormone; Circadian variation; End stage renal disease; VITAMIN-D DEFICIENCY; PLASMA PHOSPHATE; HEMODIALYSIS-PATIENTS; MORTALITY; RHYTHM; SUPPLEMENTATION; ERGOCALCIFEROL; PHOSPHORUS; METABOLISM; EXCRETION;
D O I
10.1007/s40620-014-0124-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Mineral and bone parameters are actively managed in end-stage renal disease (ESRD). However, whether these undergo circadian variation is not known. We investigated the circadian variation of mineral and bone parameters in patients on long-term hemodialysis. Methods Seventeen ESRD patients on long-term hemodialysis and eight volunteers without kidney disease were enrolled. Subjects had all medications that affect calcium-phosphate-parathyroid hormone balance (phosphate binders, vitamin D analogues, and calcimimetics) discontinued. Thereafter, for a period of 5 days, subjects consumed a diet controlled in calcium (1,200 mg per day) and phosphorus (1,000 mg per day) content. On the sixth day (a non-dialysis day for the ESRD patients), enrollees underwent twelve 2-h blood draws for phosphate, ionized calcium, parathyroid hormone (PTH), total 25-hydroxy vitamin D (25OHD), and fibroblast growth factor-23 (FGF-23). Results In the ESRD patients plasma phosphate demonstrated significant circadian variation (P < 0.00001). The peak occurred around 3: 30 am and nadir occurred around 11:00 am. Ionized calcium (P = 0.0036), PTH (P = 0.0004) and 25OHD (P = 0.009) also varied significantly during the circadian period; for ionized calcium peak and nadir occurred around 12:15 pm and 8:00 pm, parathyroid hormone 5:45 pm and 10:15 am, and 25OHD 9:45 am and 4:00 pm respectively. FGF-23 did not show a significant circadian variation. Only phosphate (P < 0.0001) and PTH (P = 0.00008) demonstrated circadian variation in the control group. Conclusions Blood concentrations of phosphate, calcium, PTH and 25-hydroxy vitamin D, exhibit a circadian variation in patients with ESRD. Knowledge of these phenomena is pertinent for the interpretation of clinical testing.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 21 条
[1]  
Agrawal R, 2000, KIDNEY, P1071
[2]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[3]  
CARRUTHERS BM, 1964, J LAB CLIN MED, V63, P959
[4]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3
[5]   Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population [J].
Floege, Juergen ;
Kim, Joseph ;
Ireland, Elizabeth ;
Chazot, Charles ;
Drueke, Tilman ;
de Francisco, Angel ;
Kronenberg, Florian ;
Marcelli, Daniele ;
Passlick-Deetjen, Jutta ;
Schernthaner, Guntram ;
Fouqueray, Bruno ;
Wheeler, David C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) :1948-1955
[6]   ALTERATION OF THE CIRCADIAN-RHYTHM OF INTACT PARATHYROID-HORMONE FOLLOWING A 96-HOUR FAST [J].
FRASER, WD ;
LOGUE, FC ;
CHRISTIE, JP ;
CAMERON, DA ;
OREILLY, DS ;
BEASTALL, GH .
CLINICAL ENDOCRINOLOGY, 1994, 40 (04) :523-528
[7]  
Fuleihan GE-H, 1997, J CLIN ENDOCR METAB, V82, P281, DOI [DOI 10.1210/JC.82.1.281, DOI 10.1210/JC.82.1.281)]
[8]   Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis [J].
Gutierrez, Orlando M. ;
Mannstadt, Michael ;
Isakova, Tamara ;
Rauh-Hain, Jose Alejandro ;
Tamez, Hector ;
Shah, Anand ;
Smith, Kelsey ;
Lee, Hang ;
Thadhani, Ravi ;
Juppner, Harald ;
Wolf, Myles .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :584-592
[9]   Phosphorus Binders and Survival on Hemodialysis [J].
Isakova, Tamara ;
Gutierrez, Orlando M. ;
Chang, Yuchiao ;
Shah, Anand ;
Tamez, Hector ;
Smith, Kelsey ;
Thadhani, Ravi ;
Wolf, Myles .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02) :388-396
[10]   Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers [J].
Jean, Guillaume ;
Terrat, Jean-Claude ;
Vanel, Thierry ;
Hurot, Jean-Marc ;
Lorriaux, Christie ;
Mayor, Brice ;
Chazot, Charles .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (11) :3670-3676